Korrektur
Chair of government’s Obesity Healthcare Goals programme was paid nearly £80 000 by GLP-1 drug firms
BMJ · 16.11.2026 · 395 · e101434
DOI: 10.1136/bmj-2026-101434 ↗Kurz gefasst
Korrektur in der Zeitschrift BMJ, online erschienen am 16.11.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Chair of government’s Obesity Healthcare Goals programme was paid nearly £80 000 by GLP-1 drug firms. BMJ, 395, e101434. https://doi.org/10.1136/bmj-2026-101434
Vancouver
Chair of government’s Obesity Healthcare Goals programme was paid nearly £80 000 by GLP-1 drug firms. BMJ. 2026;395:e101434. doi:10.1136/bmj-2026-101434
BibTeX
@article{euvimed2026,
title = {Chair of government’s Obesity Healthcare Goals programme was paid nearly £80 000 by GLP-1 drug firms},
journal = {BMJ},
year = {2026},
volume = {395},
pages = {e101434},
doi = {10.1136/bmj-2026-101434}
}
EUVIMED